Emerging trends and insights from
our leaders to yours.
Investing in Aizen Therapeutics: Unlocking New Therapeutic Frontiers with AI-Driven Peptide Design
AI Agents Are Stuck in First Gear, but 2025 Will Change That
Archon’s Jamie Lazarovits on Unlocking the Full Power of Antibodies With AI
Unlocking AI’s Business Potential: Highlights From the 2024 CIO Summit
IA Summit 2024: Navigating the Model Landscape
Madrona Prize Awarded to AI Assisted Team Communication Research
Beyond the Model: Taking AI From Prototype to Production with Unstructured’s Brian Raymond
Investing in Archon: Pioneering Next-Gen Antibody Therapies with AI & Computational Protein Design
How AI is Rewriting the SaaS Playbook